Drug intelligence / Profile preview

calcium bisglycinate

Development stage: Unknown
Lead developer: Puneet Laboratories
Modality: Small Molecules
Administration: Oral

Overview

Calcium bisglycinate is a highly bioavailable, chelated form of calcium in which a single calcium ion is bound to two molecules of the amino acid glycine. This chelation protects the calcium from binding to dietary inhibitors (such as phytates and oxalates) in the gastrointestinal tract, significantly improving its solubility and absorption compared to traditional calcium salts like calcium carbonate or calcium citrate. It is widely used as a dietary supplement and nutraceutical to support bone density, muscle function, and cardiovascular health, and to prevent or treat calcium deficiency and osteoporosis.

Other names: calcium bisglycinate chelatecalcium diglycinatecalcium glycinate

Targets

CaSR (Extracellular calcium-sensing receptor)

Beyond the preview

Go deeper on calcium bisglycinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on calcium bisglycinate.

Explore the full profile